Clinical value of novel blood‐based tau biomarkers in Creutzfeldt–Jakob disease

The increase of plasma BD-tau levels parallels that of CSF t-tau in CJD. CSF p-tau217 levels are significantly increased in CJD, reflecting a prion-specific secondary tauopathy. Plasma p-tau217 shows a distinct profile than CSF p-tau217 in CJD. Plasma BD-tau/p-tau217 ratio is as accurate as CSF 14-3-3 in distinguishing CJD from np-RPDs, including AD. BD-tau represents a valuable blood-based biomarker for CJD prognostication.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-06
DOI
https://doi.org/10.1002/alz.14422
Citations
19
Primary Topic
Prion Diseases and Protein Misfolding
Type
article
Field-Weighted Citation Impact
4.44

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical value of novel blood‐based tau biomarkers in Creutzfeldt–Jakob disease

Giuseppe Mario Bentivenga, Simone Baiardi, Piero Parchi, Bjørn‐Eivind Kirsebom et al.
19 citations
Alzheimer s & Dementia
Prion Diseases and Protein Misfolding
4.44
article

Clinical value of novel blood‐based tau biomarkers in Creutzfeldt–Jakob disease

Giuseppe Mario Bentivenga, Simone Baiardi, Piero Parchi, Bjørn‐Eivind Kirsebom, Fernando González‐Ortiz, Angela Mammana, Sabina Capellari, Kaj Blennow, Andrea Mastrangelo, Tormod Fladby, Henrik Zetterberg
article en
19 citations

Abstract

The increase of plasma BD-tau levels parallels that of CSF t-tau in CJD. CSF p-tau217 levels are significantly increased in CJD, reflecting a prion-specific secondary tauopathy. Plasma p-tau217 shows a distinct profile than CSF p-tau217 in CJD. Plasma BD-tau/p-tau217 ratio is as accurate as CSF 14-3-3 in distinguishing CJD from np-RPDs, including AD. BD-tau represents a valuable blood-based biomarker for CJD prognostication.

Alzheimer s & DementiaVol. 21(2)
University of Science and Technology of China (CN), University Hospital of North Norway (NO), University of Oslo (NO), Akershus University Hospital (NO), Sahlgrenska University Hospital (SE), Sorbonne Université (FR), Pitié-Salpêtrière Hospital (FR), Istituto delle Scienze Neurologiche di Bologna (IT), UK Dementia Research Institute (GB), Institut du Cerveau (FR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University College London (GB), UiT The Arctic University of Norway (NO), University of Gothenburg (SE), University of Bologna (IT)
Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Familjen Erling-Perssons Stiftelse, Cure Alzheimer's Fund, Stiftelsen för Gamla Tjänarinnor, EU Joint Programme – Neurodegenerative Disease Research, European Partnership on Metrology, National Institute for Health and Care Research, University College London, European Commission, Ministero della Salute, Hjärnfonden, Vetenskapsrådet, Norges Forskningsråd, UK Dementia Research Institute, Fondation pour la Recherche sur Alzheimer, HORIZON EUROPE Framework Programme
Good health and well-being
Openalex Percentile: Top 4%
Prion Diseases and Protein Misfolding
4.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.